The report is designed to provide the animal health industry executives with
strategically significant competitor information, analysis and insight,
critical to the development and implementation of effective marketing and R&D
programs. The study' s major objectives include:
To establish a comprehensive, factual and cost-effective information base
on performance, capabilities, goals and strategies of the world' s leading
animal health companies.
To help current suppliers realistically assess their technological and
marketing capabilities vis-a-vis leading competitors.
To assist potential market entrants in evaluating prospective acquisitions
and joint venture candidates.
To complement organizations' internal competitor information gathering
efforts by providing strategic analysis, data interpretation, and insight.
To identify the least competitive market niches with significant growth
potential.
Contains 400 pages and 55 tables
Table of Contents
Table of Contents
WORLDWIDE MARKET OVERVIEW
The study will provide a strategic overview of the worldwide animal health
market, including:
Five-year forecasts for:
Major market segments.
Key geographic regions.
Assessment of major U.S. and international trends with potentially
significant impact on the animal health industry during the next five years,
including discussion of such issues as pricing, industry consolidation, market
globalization, growing R&D cost, generics, as well as advances in genomics,
proteomics, drug screening, tissue engineering, bioinformatics and other
technologies.
Analysis of key market segments.
Review of major geographic areas.
COMPANY STRATEGIC ASSESSMENTS
The following companies have been selected as the Top 10 suppliers with the
highest worldwide sales of animal health products:
For each of the Top 10 companies, the report will provide the following
information:
SECTION I: BUSINESS ORGANIZATION
History of the company' s animal health business evolution, which is
important to the understanding of its corporate culture, management mentality
and strategies.
Most recent significant M&A activity and organizational changes.
Current organizational structure.
SECTION II: SENIOR MANAGEMENT
Names, titles and background of key executives.
SECTION III: FACILITIES AND EMPLOYEES
Major administrative, manufacturing and R&D facilities in the U.S. and
abroad.
Manufacturing practices.
New plants under construction.
U.S. and international work force.
SECTION IV:TECHNOLOGICAL KNOW-HOW
Internally developed and acquired animal health technologies, processes
and related capabilities.
Proprietary technologies and patent litigations.
SECTION V: PRODUCT PORTFOLIO
Extensive review of major product lines.
Recently introduced products and line extensions.
SECTION VI: MARKETING TACTICS
Sales force size in the U.S. and other markets.
Promotional tactics.
Distribution approaches.
Product service and support.
Customer relations.
SECTION VII: FINANCIAL ANALYSIS
Sales of animal health products by division, product line, geographic
region and country.
Five-year sales and operating profit performance.
SECTION VIII: R&D EXPENDITURES AND MAJOR PROGRAMS
Estimated R&D budget.
Research facilities and staff.
New technologies, products and applications in R&D, including their
development phase and introduction dates.
SECTION IX: COLLABORATIVE ARRANGEMENTS
Major joint ventures, distribution, O.E.M. and licensing partners, both
industrial and academic.
Terms of collaborative agreements and specific products involved.
SECTION X: STRATEGIC DIRECTION
Specific business, new product development and marketing strategies
Anticipated acquisitions, joint ventures and divestitures.
Major strengths and weaknesses.
COMPARATIVE ANALYSIS
In this section of the report, the Top 10 companies are ranked according to
the following criteria:
Worldwide sales of animal health products.
Sales estimated in North America, Europe, Japan and other geographic
regions.
Operating profit and margins.
R&D expenditures, and others.
LIST OF TABLES
TABLE MO-1: WORLD ANIMAL HEALTH MARKET BY SEGMENT
TABLE MO-2: WORLD ANIMAL HEALTH MARKET FORECAST BY SEGMENT
TABLE MO-3: WORLD ANIMAL HEALTH MARKET BY GEOGRAPHIC REGION
TABLE MO-4: WORLD ANIMAL HEALTH MARKET FORECAST BY GEOGRAPHIC REGION
TABLE MO-5: WORLD ANIMAL HEALTH MARKET BY SPECIES
TABLE MO-6: WORLD ANIMAL HEALTH MARKET FORECAST BY SPECIES
TABLE AL-1: ALPHARMA SALES BY BUSINESS SEGMENT
TABLE AL-2: ALPHARMA OPERATING PROFIT BY BUSINESS SEGMENT
TABLE AL-3: ALPHARMA SALES AND OPERATING PROFIT GROWTH
TABLE AL-4: ALPHARMA SALES BY COUNTRY
TABLE AL-5: ALPHARMA SALES BY PRODUCT LINE
TABLE BA-1: BAYER ANIMAL HEALTH SALES AND OPERATING PROFIT GROWTH
TABLE BA-2: BAYER ANIMAL HEALTH SALES BY GEOGRAPHIC REGION
TABLE BA-3: BAYER ANIMAL HEALTH SALES BY PRODUCT CATEGORY
TABLE BA-4: BAYER ANIMAL HEALTH SALES BY INDIVIDUAL PRODUCT
TABLE BI-1: BOEHRINGER INGELHEIM SALES BY DIVISION
TABLE BI-2: BOEHRINGER INGELHEIM SALES AND OPERATING PROFIT GROWTH
TABLE BI-3: BOEHRINGER INGELHEIM SALES BY THERAPEUTIC CATEGORY
TABLE BI-4: BOEHRINGER INGELHEIM SALES BY MAJOR PRODUCT
TABLE BI-5: BOEHRINGER INGELHEIM SALES GROWTH BY MAJOR PRODUCT
TABLE BI-6: BOEHRINGER INGELHEIM SALES BY GEOGRAPHIC REGION
TABLE BI-7: BOEHRINGER INGELHEIM SALES GROWTH BY GEOGRAPHIC REGION
TABLE EL-1: ELI LILLY/ELANCO SALES BY BUSINESS SEGMENT
TABLE EL-2: ELI LILLY/ELANCO SALES GROWTH BY BUSINESS SEGMENT
TABLE EL-3: ELI LILLY/ELANCO ANIMAL HEALTH SALES BY GEOGRAPHIC REGION
TABLE MI-1: MERIAL-INTERVET SALES AND OPERATING PROFIT GROWTH
TABLE MI-2: MERIAL-INTERVET SALES BY PRODUCT LINE
TABLE MI-3: MERIAL-INTERVET SALES GROWTH BY PRODUCT LINE
TABLE NO-1: NOVARTIS ANIMAL HEALTH SALES AND OPERATING PROFIT GROWTH
TABLE NO-1: NOVARTIS SALES AND OPERATING PROFIT GROWTH
TABLE NO-2: NOVARTIS SALES BY BUSINESS SEGMENT
TABLE NO-3: NOVARTIS SALES GROWTH BY BUSINESS SEGMENT
TABLE NO-4: NOVARTIS OPERATING PROFIT BY BUSINESS SEGMENT
TABLE NO-5: NOVARTIS OPERATING PROFIT GROWTH BY BUSINESS SEGMENT
TABLE NO-6: NOVARTIS SALES BY COUNTRY
TABLE NO-7: NOVARTIS SALES GROWTH BY COUNTRY
TABLE NO-8: NOVARTIS SALES BY THERAPEUTIC CATEGORY
TABLE NO-9: NOVARTIS SALES GROWTH BY THERAPEUTIC CATEGORY
TABLE NO-10: NOVARTIS SALES OF TOP 20 DRUGS
TABLE NO-11: NOVARTIS SALES GROWTH BY MAJOR DRUG
TABLE PF-1: PFIZER SALES BY DIVISION
TABLE PF-2: PFIZER SALES AND OPERATING PROFIT GROWTH
TABLE PF-3: PFIZER SALES BY THERAPEUTIC CATEGORY
TABLE PF-4: PFIZER SALES BY MAJOR PRODUCT
TABLE PF-5: PFIZER SALES GROWTH BY MAJOR PRODUCT
TABLE PF-6: PFIZER SALES BY GEOGRAPHIC REGION
TABLE PF-7: PFIZER SALES GROWTH BY GEOGRAPHIC REGION
TABLE PH-1: PHIBRO SALES BY BUSINESS SEGMENT
TABLE PH-2: PHIBRO SALES GROWTH BY BUSINESS SEGMENT
TABLE PH-3: PHIBRO OPERATING PROFIT AND MARGINS BY BUSINESS SEGMENT
TABLE PH-4: PHIBRO OPERATING PROFIT GROWTH BY BUSINESS SEGMENT
TABLE PH-5: PHIBRO SALES BY COUNTRY/GEOGRAPHIC REGION
TABLE VE-1: VETOQUINOL SALES BY DIVISION
TABLE VE-2: VETOQUINOL SALES AND OPERATING PROFIT GROWTH
TABLE VE-3: VETOQUINOL SALES BY THERAPEUTIC CATEGORY
TABLE VE-4: VETOQUINOL SALES BY MAJOR PRODUCT
TABLE VE-5: VETOQUINOL SALES GROWTH BY MAJOR PRODUCT
TABLE VE-6: VETOQUINOL SALES BY GEOGRAPHIC REGION
TABLE VE-7: VETOQUINOL SALES GROWTH BY GEOGRAPHIC REGION
TABLE VI-1: VIRBAC SALES BY GEOGRAPHIC REGION
TABLE VI-2: VIRBAC SALES BY MARKET BY SEGMENT
The 2011 Top Ten World's Leading Animal Health Companies published by Venture Planning Group in January 1, 2010. This report price starts from US $ 12500.
The contents of this page may be different from the latest version. Please contact us for details.
